Oruka Therapeutics (ORKA)
NASDAQ:ORKA
ORKA Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ORKA Stock 12 Month Forecast
Average Price Target
$71.33
▲(15.04% Upside)
| Highest Price Target$125.00 | Average Price Target$71.33 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$125
Buy
101.58%
Upside
Reiterated
04/09/26
Barclays
$50→$78
Buy
25.79%
Upside
Assigned
04/07/26
UBS
$50→$75
Buy
20.95%
Upside
Assigned
04/06/26
Piper Sandler
$75
Buy
20.95%
Upside
Reiterated
03/24/26
Leerink Partners
$58→$86
Buy
38.69%
Upside
Reiterated
03/16/26
TD Cowen
―
Buy
―
Reiterated
03/16/26
LifeSci Capital
$71
Buy
14.50%
Upside
Reiterated
03/13/26
Stifel Nicolaus
$47→$72
Buy
16.11%
Upside
Reiterated
03/13/26
Wedbush
$45
Buy
-27.43%
Downside
Reiterated
03/13/26
Jefferies
$45
Buy
-27.43%
Downside
Reiterated
03/11/26
BTIG
$63→$73
Buy
17.72%
Upside
Reiterated
02/02/26
H.C. Wainwright
$40
Buy
-35.49%
Downside
Reiterated
01/21/26
Clear Street
$46→$71
Buy
14.50%
Upside
Reiterated
01/13/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$125
Buy
101.58%
Upside
Reiterated
04/09/26
Barclays
$50→$78
Buy
25.79%
Upside
Assigned
04/07/26
UBS
$50→$75
Buy
20.95%
Upside
Assigned
04/06/26
Piper Sandler
$75
Buy
20.95%
Upside
Reiterated
03/24/26
Leerink Partners
$58→$86
Buy
38.69%
Upside
Reiterated
03/16/26
TD Cowen
―
Buy
―
Reiterated
03/16/26
LifeSci Capital
$71
Buy
14.50%
Upside
Reiterated
03/13/26
Stifel Nicolaus
$47→$72
Buy
16.11%
Upside
Reiterated
03/13/26
Wedbush
$45
Buy
-27.43%
Downside
Reiterated
03/13/26
Jefferies
$45
Buy
-27.43%
Downside
Reiterated
03/11/26
BTIG
$63→$73
Buy
17.72%
Upside
Reiterated
02/02/26
H.C. Wainwright
$40
Buy
-35.49%
Downside
Reiterated
01/21/26
Clear Street
$46→$71
Buy
14.50%
Upside
Reiterated
01/13/26
Best Analysts Covering Oruka Therapeutics
3 Months
xxx
Success Rate
7/7 ratings generated profit
Average Return
+55.67%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +55.67% per trade.
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+127.03%
Copying Julian Harrison's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +127.03% per trade.
2 Years
xxx
Success Rate
9/9 ratings generated profit
Average Return
+173.97%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +173.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ORKA Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
11
13
9
14
11
Buy
4
4
3
5
5
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
17
12
19
16
Each month's total comprises the sum of three months' worth of ratings.
ORKA Financial Forecast
ORKA Stock Forecast FAQ
What is ORKA’s average 12-month price target, according to analysts?
Based on analyst ratings, Oruka Therapeutics’s 12-month average price target is 71.33.
What is ORKA’s upside potential, based on the analysts’ average price target?
Oruka Therapeutics has 15.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ORKA a Buy, Sell or Hold?
Oruka Therapeutics has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oruka Therapeutics’s price target?
The average price target for Oruka Therapeutics is 71.33. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $125.00 ,the lowest forecast is $40.00. The average price target represents 15.04% Increase from the current price of $62.01.
The highest analyst price target is $125.00 ,the lowest forecast is $40.00. The average price target represents 15.04% Increase from the current price of $62.01.
What do analysts say about Oruka Therapeutics?
Oruka Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of ORKA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.